These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29076553)

  • 1. Reverse and Forward Translational Neuropharmacology in Psychiatric Drug Discovery.
    Shaffer CL
    Clin Pharmacol Ther; 2018 Feb; 103(2):193-195. PubMed ID: 29076553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Centered Reverse Translation.
    Wagner JA
    Clin Pharmacol Ther; 2018 Feb; 103(2):168-170. PubMed ID: 29210055
    [No Abstract]   [Full Text] [Related]  

  • 3. Model-Informed Reverse and Forward Translation of Safety Risks in Drug Development.
    Mettetal JT
    Clin Pharmacol Ther; 2018 Feb; 103(2):199-201. PubMed ID: 29194584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse Translation: The Art of Cyclical Learning.
    Kasichayanula S; Venkatakrishnan K
    Clin Pharmacol Ther; 2018 Feb; 103(2):152-159. PubMed ID: 29313963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development.
    Gibbs JP; Menon R; Kasichayanula S
    Clin Pharmacol Ther; 2018 Feb; 103(2):196-198. PubMed ID: 29105747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Well Are We Applying Quantitative Methods to Reverse Translation to Inform Early Clinical Development?
    Heatherington AC; Kasichayanula S; Venkatakrishnan K
    Clin Pharmacol Ther; 2018 Feb; 103(2):174-176. PubMed ID: 29274086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing Clinical Prediction Models: Pushing the Needle Towards Precision Pharmacotherapy.
    Dorajoo SR; Chan A
    Clin Pharmacol Ther; 2018 Feb; 103(2):180-183. PubMed ID: 28722146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Next Generation of Drug Safety Science: Coupling Detection, Corroboration, and Validation to Discover Novel Drug Effects and Drug-Drug Interactions.
    Tatonetti NP
    Clin Pharmacol Ther; 2018 Feb; 103(2):177-179. PubMed ID: 29313964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery.
    't Hart BA; Laman JD; Kap YS
    Clin Pharmacol Ther; 2018 Feb; 103(2):262-270. PubMed ID: 28748631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response.
    Brackman DJ; Giacomini KM
    Clin Pharmacol Ther; 2018 Feb; 103(2):233-242. PubMed ID: 29023674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality.
    Miksad RA; Abernethy AP
    Clin Pharmacol Ther; 2018 Feb; 103(2):202-205. PubMed ID: 29214638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging Humanized Animal Models to Understand Human Drug Disposition: Opportunities, Challenges, and Future Directions.
    Choo EF; Salphati L
    Clin Pharmacol Ther; 2018 Feb; 103(2):188-192. PubMed ID: 29193027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy From Strange Sources.
    Lesko LJ
    Clin Pharmacol Ther; 2018 Feb; 103(2):253-261. PubMed ID: 29052220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence.
    Rostami-Hodjegan A
    Clin Pharmacol Ther; 2018 Feb; 103(2):224-232. PubMed ID: 29023678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.
    Wang L; Ingle J; Weinshilboum R
    Clin Pharmacol Ther; 2018 Feb; 103(2):243-252. PubMed ID: 29052219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational High-Dimensional Drug Interaction Discovery and Validation Using Health Record Databases and Pharmacokinetics Models.
    Chiang CW; Zhang P; Wang X; Wang L; Zhang S; Ning X; Shen L; Quinney SK; Li L
    Clin Pharmacol Ther; 2018 Feb; 103(2):287-295. PubMed ID: 29052226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of ketamine and toxic interactions with psychostimulants.
    Hayase T; Yamamoto Y; Yamamoto K
    BMC Neurosci; 2006 Mar; 7():25. PubMed ID: 16542420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges for Training Translational Researchers in the Era of Ubiquitous Data.
    Altman RB
    Clin Pharmacol Ther; 2018 Feb; 103(2):171-173. PubMed ID: 29134624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.
    Krystal JH
    Arch Gen Psychiatry; 2010 Nov; 67(11):1110-1. PubMed ID: 21041611
    [No Abstract]   [Full Text] [Related]  

  • 20. (+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics.
    Cilia J; Hatcher P; Reavill C; Jones DN
    J Psychopharmacol; 2007 May; 21(3):302-11. PubMed ID: 17591657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.